Disclaimer: Consult with a doctor before deciding on a treatment plan for cancer.
In the early 1900’s, doctors experimented with pancreatic enzymes and found that these substances were able to dissolve the outer fibrin sheath that protects cancer cells from the body’s immune system. People rarely develop cancer in the first part of their duodenum where pancreatic juices are dumped into the digestive tract with the risk of cancer increasing as the distance from this location increases. Pancreatic enzymes that aren’t used during digestion are absorbed into the blood stream and they travel throughout the body, finding cancer cells and dissolving their outer fibrin sheaths. Unfortunately, the typical American diet that includes a lot of animal products requires a lot of pancreatic enzymes for digestion and that leaves no enzymes for absorption to travel through the rest of the body, searching for cancer cells. Taking pancreatic enzyme supplements can be extremely beneficial, as part of a cancer protocol to make cancer cells vulnerable to attack by the immune system.
Enzymatic cancer therapy is a helper-therapy that’s usually combined with other cancer treatments. Enzymatic treatments for cancer originate from Dr. John Beard, an embryologist who noted the similarities between pre-embryonic trophoblasts and cancer cells. His theories regarding the similarities between trophoblasts and cancer cells date back to 1906. Essentially, he saw cancerous tumors as false placentas. Dr. Beard’s thinking was known as the Trophoblast Theory of Cancer. Another piece of information lending credibility to the value of pancreatic enzymes is the fact that cancer almost never occurs in the first segment of the small intestine (the duodenum) where pancreatic juices are secreted via the pancreatic duct. The relative prevalence of cancer increases as one moves further down the digestive tract, away from the region where pancreatic juices are secreted .
Dr. Beard believed the enzyme therapy would be a valuable treatment for all types of cancer because pancreatic enzymes have the ability to dissolve the protective protein coating on cancer cells. Medical literature from the early 1900’s documented tumor regression in terminal cancer patients who were treated using enzyme therapy . Since that time, cancer research has shown that pancreatic enzymes can break down the protein-coating that normally protects cancer cells from attack by white blood cells and the patient’s own immune system.
Throughout the 20th century, most scientists believed that pancreatic enzymes were produced in the pancreas, delivered to the small intestine for use and then deactivated and excreted from the body in the feces. But research has shown that in fact, pancreatic enzymes are re-circulated in a manner similar to how bile salts are recirculated via enterohepatic circulation. Since pancreatic enzymes are among the most difficult biomolecules for the body to manufacture it makes sense that unused pancreatic enzymes would be recirculated in the body .
The recirculation of pancreatic enzymes is important because their presence in the blood demonstrates that they can reach and have an impact on all areas of the body. Foods that use too many of the enzymes deplete the pancreas of its stores which can lead to a variety of disease-states, demonstrating the important role of diet in preventing cancer and other diseases. . Pancreatic enzymes are an important part of many integrative cancer treatments because they help patients digest their food down to the components that are absorbed readily by the body. They help ensure proper nutrition and absorption of the necessary nutritional components in food since cancer patients are often deficient in a variety of these things. As such pancreatic enzymes have an impact on the following physical ailments including:
- Digestive issues
- Diabetic ulcers
- Injury-related disorders (e.g. contusions, lacerations, sprains, strains, muscle injuries)
Despite its success, unfortunately, after Dr. Beard’s death in 1923, pancreatic proteolytic enzyme therapy was swept under the rug and forgotten until recently .
The use of systemic pancreatic enzyme therapy has been used by doctors since the early part of the 1900’s. The pancreatic enzymes are effective in the treatment of cancer with very low toxicity. . Generally, however, pancreatic enzyme therapy is combined with a therapeutic cancer diet along with other cancer-fighting treatments .
Dr. Kelley’s Enzyme Therapy
William Donald Kelley was a doctor who studied Dr. Beard’s theories to cure himself of metastatic pancreatic cancer after he’d been given only two months to live. This therapy uses high doses of pancreatic enzymes and regular coffee enemas. There are no side effects involved with Dr. Kelley’s Enzyme Therapy and on newly diagnosed cancer patients, this treatment approach had a 93% success rate with the 33,000 patients Dr. Kelley and his practitioners treated .
Using only pancreatic enzymes, patients who had advanced cancer had a lower chance of survival (about 25-50%) with this treatment but enzymes can be combined with other integrative cancer treatments (a cancer protocol) to raise the cure rate. Dr. Kelley believed that having a healthy pancreas was pivotal in fighting cancer. The pancreas and the liver work together to regulate insulin and the pancreas produces enzymes that can dissolve protein (including the proteins that protects cancer cells) .
When a patient has the proper amount of trace minerals in the body along with hormonal balance, their pancreatic enzymes can also be properly balanced. Kelley noted, for example, that high doses of vitamin C can disrupt enzyme function in the body. He didn’t use high doses of vitamin C in his treatment. Rather, he advocated for juicing specific vegetable combinations to support the glands in the body and thus hormonal balance .
Dr. Kelley believed that cancer and diabetes were correlated. He treated them both in a similar way .
Dr. Kelley’s Enzyme Therapy is often used in conjunction with the Cellect-Budwig Protocol which combines a specially formulated nutritional powder with a special diet, vegetable juicing, laetrile supplementation, and electromedicine (e.g. use of a Rife Machine). .
Pancreatic Enzyme Basics
Throughout the 20th century, most scientists and doctors believed that new pancreatic proteolytic enzymes were manufactured and secreted into the small intestine on demand. These digestive enzymes were not circulated and recycled according to this traditional belief. But research has shown that, in fact, proteolytic pancreatic enzymes are recirculated similar to bile salts in enterohepatic circulation .
Pancreatic enzymes make up a significant portion of blood. In fact, the second most abundant blood protein after albumin is alpha-anti-trypsin, a trypsin inhibitor .
Below is a list of the known pancreatic enzymes and their function in the body:
Proteases digest proteins. They play a role in controlling anxiety and insomnia .
There are three proteases:
Cholecystokinin (a peptide produced by neurons in the enteric nervous system) spurs the secretion of trypsinogen into the small intestine via the pancreatic duct from the pancreas .
Trypsin travels to the small intestine from the pancreas in an inactive form known as trypsinogen. This inactive form makes it safe for handling while its en route to the small intestine. When it reaches the digestive system the trypsinogen is activated by an enzyme in the mucosa of the small intestine called enterokinase .
Trypsin, in turn, activates chymotrypsin .
Trypsin and chymotrypsin digest proteins into smaller units called peptides. Then, peptidase digests the peptides into amino acids for absorption. It also regulates the activity of other enzymes .
Research has linked trypsin to chronic pancreatitis and cystitic fibrosis. Studies have also shown that trypsin could be helpful in alleviating serious skin problems .
Chymotrypsinogen (the inactive pro-enzyme form of the enzyme) is activated by trypsin. As such, these two enzymes work together . Chymotrypsin is crucial for healthy blood clotting and for the metabolism of the HIV virus .
Present in plants as well as humans. Plays a role in controlling: inflammatory conditions, cancer, the immune system, and blood flow. Peptidase helps the immune system by digesting bacterial, viral, and parasitic invasions. It can help reduce inflammation in inflammatory bowel disease and can stop tumor formation in the lower bowel .
Pancreatic lipase digests triglycerides (the main constituents of natural fats and oils). They break triglycerides down into two mono-glycerides and two free fatty acids. It is secreted into the small intestine via the pancreatic duct as a component in pancreatic juice. In order for pancreatic lipase to do its work digesting triglycerides, bile salts must be present in the small intestine in sufficient quantities. As such, both the liver and the pancreas play a role in digesting fats .
Amylases digest starches or carbohydrates. Starch is the primary storage form of glucose in plants. It is primarily present in the pancreas, but also found in saliva .
Ribonuclease breaks RNA down into smaller components.
An enzyme that breaks down DNA.
Gelatinase is a proteolytic enzyme that breaks down gelatin into smaller components.
A pancreatic enzyme that breaks down elastin into smaller components.
Other Important Information
Dr. Beard believed that pancreatic enzymes had to be injected into the bloodstream in order to prevent them from being destroyed by acids in the stomach. But research has shown that oral pancreatic enzymes pass intact into the small intestine where they’re absorbed into the blood stream for use throughout the body. The enzymes are recycled by the body and returned to the pancreas .
Pancreatic enzymes in supplement form are often derived from pigs .
 Gonzalez, N. J. (2017). Enzyme Therapy and Cancer. Retrieved April 24, 2018 from http://www.dr-gonzalez.com/history_of_treatment.htm
 Griffin, G. E. (1974). World Without Cancer: The Story of Vitamin B17, 3rd Ed. American Media.
 Campbell, J. T. (1907). Trypsin treatment of a malignant disease. Retrieved April 24, 2018 from https://jamanetwork.com/journals/jama/article-abstract/461960?redirect=true
 Goeth, R. A. (1907). Pancreatic treatment of cancer, with report of a cure. Retrieved April 24, 2018 from https://jamanetwork.com/journals/jama/article-abstract/462754?redirect=true
 Wiggins, F. H. (1906). Case of multiple fibrosarcoma of the tongue, with remarks on the use of trypsin and amylopsin in the treatment of malignant disease. Retrieved April 24, 2018 from https://jamanetwork.com/journals/jama/article-abstract/461549?redirect=true
 Liebow, C. & Rothman, S. S. (1975). Enteropancreatic circulation of digestive enzymes. Retrieved April 24, 2018 from https://www.ncbi.nlm.nih.gov/pubmed/1154022
 Rothman, S., Liebow, C., Isenman, L. (2002). Conservation of Digestive Enzymes. Retrieved April 24, 2018 from https://pdfs.semanticscholar.org/779c/9f7e1ef161a7a21f2ecd18e86b141780529c.pdf
 Vasquez, Al. (2014). Molecular and Physiologic Mechanisms of Systemic Enzyme Therapy: A Review for Clinicians. Retrieved April 24, 2018 from http://www.nutritionalwellness.com/archives/2007/feb/02_vasquez.php
 Binzel, P. E. Jr. (1994). Alive and Well: One Doctor’s Experience With Nutrition in the Treatment of Cancer Patients. American Media.
 Taussig, S. & Batkin, S. (1988). Bromelain, the enzyme complex of pineapple (Ananas comosus) and its clinical application. An update. Retrieved April 24, 2018 from https://www.sciencedirect.com/science/article/pii/0378874188901274
 Vivo Pathophysiology (n.d.). Exocrine Secretions of the Pancreas. Retrieved April 24, 2018 from http://www.vivo.colostate.edu/hbooks/pathphys/digestion/pancreas/exocrine.html
 World of Enzymes and Probiotics (2013). Peptidase. Retrieved April 24, 2018 from http://worldofenzymes.info/enzymes-introduction/peptidase/
 World of Enzymes and Probiotics (2013). Trypsin. Retrieved April 24, 2018 from http://worldofenzymes.info/enzymes-introduction/trypsin/
 Vivo Pathophysiology (n.d.). Cholecystokinin. Retrieved April 24, 2018 from http://www.vivo.colostate.edu/hbooks/pathphys/endocrine/gi/cck.html
 Worthington Biochemical Corporation (2018). Chymotrypsin. Retrieved April 24, 2018 from http://www.worthington-biochem.com/chy/default.html
 Proteopedia.org (n.d.). Chymotrypsin. Retrieved April 24, 2018 from http://proteopedia.org/wiki/index.php/Chymotrypsin
 National Cancer Institute (n.d.). Gonzalez Regimen (PDQ®)–Health Professional Version.
Retrieved April 24, 2018 from https://www.cancer.gov/about-cancer/treatment/cam/hp/gonzalez-pdq
 Conners Clinic (n.d.). Dr. Kelley’s Enzyme Therapy. Retrieved May 2, 2018 from http://www.connersclinic.com/cancer-and-enzyme-therapy/
 Cancer Tutor (2018). Kelley Metabolic Protocol. Retrieved May 2, 2018 from https://www.cancertutor.com/metabolic/
 Cancer Tutor (2018). Cellect-Budgwig Protocol. Retrieved May 2, 2018 from https://www.cancertutor.com/cellect_budwig/
 Fonorow, O. R. (2003). The Cure for Cancer: Theory, History, and Treatment. Retrieved May 2, 2018 from http://internetwks.com/owen/CancerCure.htm